EB
Emergent Biosolutions Inc
🇩🇪XSTU.ER4GermanyHealthcare
€5.50EURdown -0.03 (-0.54%)OpenEnd of day7:29 PM
Price€5.50-0.03 (-0.54%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US29089Q1058
- CUSIP
- Not reported
Company
- Employees
- 900
- Headquarters
- Gaithersburg, United States
- CEO
- Mr. Joseph C. Papa Jr., M.B.A., R.Ph.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Oct 28, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $770.2M-9.56%down year on year
- Net income
- -$176.8M-226.74%down year on year
- Gross margin
- 49.4%-11.37%down year on year
- Free cash flow
- $85.9M-44.58%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.